Home / Facilities / 3004408187

Meda Pharmaceuticals Inc. FDA Inspection Record

FEI 3004408187 · Inspections, Form 483s, warning letters and import refusals

Meda Pharmaceuticals Inc. is an FDA-inspected facility (FEI 3004408187) located in Somerset, NJ, US. RegDataLab tracks 2 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Aug 5, 2011: No Action Indicated (NAI)
Inspections on record
2 (2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
2, latest Oct 17, 2011
Import refusals
2

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 5, 2011No Action Indicated (NAI)No citations listed
Sep 17, 2010No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 17, 2011Class IID-1418-2012Prefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC industries, Inc…
Labeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the…
May 29, 2008Class IID-170-2009Soma Compound Tablets USP, Carisoprodol 200 mg and aspirin 325 mg, Rx only, 100… and 1 more product
Superpotent: 12 month stability (by mfr Actavis, Totowa, NJ)

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 15, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

2 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-1418-2012, this FEI as the recalling firmOct 17, 201110 years or older, so it adds no points0
Class II recall D-170-2009, this FEI as the recalling firmMay 29, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 15, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 15, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 15, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Meda Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Meda Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Meda Pharmaceuticals Inc.
Location
Somerset, NJ (US)
Source
inspections

Import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.